MiMedx Group is streamlining operations by eliminating the Chief Operating Officer role and implementing broad expense reductions. The company aims to pivot resources toward its growing surgical business while managing a slow recovery in wound care.
- Elimination of COO role held by Ricci Whitlow
- Targeted operating expense reduction of $40 million
- One-time Q2 2026 restructuring charge of $4 million
- Increased investment in flourishing surgical business
- Slow recovery in wound care following Medicare reimbursement cuts
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.